nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0798	0.105	CbGbCtD
Cabazitaxel—CYP2C8—Tazarotene—psoriasis	0.0531	0.0697	CbGbCtD
Cabazitaxel—CYP3A5—Beclomethasone—psoriasis	0.0514	0.0674	CbGbCtD
Cabazitaxel—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0465	0.0609	CbGbCtD
Cabazitaxel—ABCG2—Mycophenolate mofetil—psoriasis	0.0369	0.0484	CbGbCtD
Cabazitaxel—SLCO1B1—Cyclosporine—psoriasis	0.0352	0.0462	CbGbCtD
Cabazitaxel—SLCO1B3—Methotrexate—psoriasis	0.032	0.042	CbGbCtD
Cabazitaxel—ABCG2—Hydrocortisone—psoriasis	0.0296	0.0388	CbGbCtD
Cabazitaxel—ABCG2—Cyclosporine—psoriasis	0.028	0.0367	CbGbCtD
Cabazitaxel—CYP2C8—Cholecalciferol—psoriasis	0.0227	0.0297	CbGbCtD
Cabazitaxel—CYP3A5—Mycophenolate mofetil—psoriasis	0.0205	0.0268	CbGbCtD
Cabazitaxel—CYP2C8—Mycophenolate mofetil—psoriasis	0.0197	0.0258	CbGbCtD
Cabazitaxel—SLCO1B1—Methotrexate—psoriasis	0.0186	0.0244	CbGbCtD
Cabazitaxel—ABCG2—Dexamethasone—psoriasis	0.0184	0.0242	CbGbCtD
Cabazitaxel—CYP3A4—Calcitriol—psoriasis	0.0179	0.0234	CbGbCtD
Cabazitaxel—CYP3A5—Hydrocortisone—psoriasis	0.0164	0.0215	CbGbCtD
Cabazitaxel—CYP2C8—Hydrocortisone—psoriasis	0.0158	0.0207	CbGbCtD
Cabazitaxel—CYP3A5—Cyclosporine—psoriasis	0.0155	0.0203	CbGbCtD
Cabazitaxel—CYP2C8—Cyclosporine—psoriasis	0.0149	0.0195	CbGbCtD
Cabazitaxel—ABCG2—Methotrexate—psoriasis	0.0148	0.0194	CbGbCtD
Cabazitaxel—CYP3A4—Methoxsalen—psoriasis	0.0139	0.0182	CbGbCtD
Cabazitaxel—ABCB1—Mycophenolate mofetil—psoriasis	0.0133	0.0175	CbGbCtD
Cabazitaxel—ABCB1—Betamethasone—psoriasis	0.0114	0.015	CbGbCtD
Cabazitaxel—ABCB1—Prednisolone—psoriasis	0.0113	0.0148	CbGbCtD
Cabazitaxel—ABCB1—Hydrocortisone—psoriasis	0.0107	0.014	CbGbCtD
Cabazitaxel—ABCB1—Prednisone—psoriasis	0.0106	0.014	CbGbCtD
Cabazitaxel—CYP3A5—Dexamethasone—psoriasis	0.0102	0.0134	CbGbCtD
Cabazitaxel—ABCB1—Cyclosporine—psoriasis	0.0101	0.0132	CbGbCtD
Cabazitaxel—CYP2C8—Dexamethasone—psoriasis	0.00982	0.0129	CbGbCtD
Cabazitaxel—CYP3A4—Cholecalciferol—psoriasis	0.0092	0.0121	CbGbCtD
Cabazitaxel—CYP3A4—Mycophenolate mofetil—psoriasis	0.00798	0.0105	CbGbCtD
Cabazitaxel—CYP3A4—Triamcinolone—psoriasis	0.00798	0.0105	CbGbCtD
Cabazitaxel—CYP3A4—Betamethasone—psoriasis	0.00684	0.00897	CbGbCtD
Cabazitaxel—CYP3A4—Prednisolone—psoriasis	0.00675	0.00885	CbGbCtD
Cabazitaxel—ABCB1—Dexamethasone—psoriasis	0.00664	0.00871	CbGbCtD
Cabazitaxel—CYP3A4—Hydrocortisone—psoriasis	0.0064	0.00839	CbGbCtD
Cabazitaxel—CYP3A4—Prednisone—psoriasis	0.00638	0.00836	CbGbCtD
Cabazitaxel—CYP3A4—Cyclosporine—psoriasis	0.00605	0.00793	CbGbCtD
Cabazitaxel—ABCB1—Methotrexate—psoriasis	0.00534	0.007	CbGbCtD
Cabazitaxel—CYP3A4—Dexamethasone—psoriasis	0.00398	0.00522	CbGbCtD
Cabazitaxel—TUBB6—Vitamin A—Acitretin—psoriasis	0.00168	0.323	CbGdCrCtD
Cabazitaxel—TUBB6—Tretinoin—Acitretin—psoriasis	0.00117	0.226	CbGdCrCtD
Cabazitaxel—TUBB6—Isotretinoin—Acitretin—psoriasis	0.00117	0.226	CbGdCrCtD
Cabazitaxel—TUBB6—Alitretinoin—Acitretin—psoriasis	0.00117	0.226	CbGdCrCtD
Cabazitaxel—Myalgia—Triamcinolone—psoriasis	0.000143	0.000617	CcSEcCtD
Cabazitaxel—Nervous system disorder—Hydrocortisone—psoriasis	0.000142	0.000616	CcSEcCtD
Cabazitaxel—Pneumonia—Methotrexate—psoriasis	0.000142	0.000616	CcSEcCtD
Cabazitaxel—Eye disorder—Prednisone—psoriasis	0.000142	0.000615	CcSEcCtD
Cabazitaxel—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000142	0.000615	CcSEcCtD
Cabazitaxel—Decreased appetite—Cyclosporine—psoriasis	0.000142	0.000614	CcSEcCtD
Cabazitaxel—Tachycardia—Hydrocortisone—psoriasis	0.000142	0.000613	CcSEcCtD
Cabazitaxel—Infestation NOS—Methotrexate—psoriasis	0.000142	0.000612	CcSEcCtD
Cabazitaxel—Infestation—Methotrexate—psoriasis	0.000142	0.000612	CcSEcCtD
Cabazitaxel—Flushing—Prednisone—psoriasis	0.000141	0.00061	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000141	0.00061	CcSEcCtD
Cabazitaxel—Skin disorder—Hydrocortisone—psoriasis	0.000141	0.00061	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Dexamethasone—psoriasis	0.000141	0.00061	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Betamethasone—psoriasis	0.000141	0.00061	CcSEcCtD
Cabazitaxel—Discomfort—Triamcinolone—psoriasis	0.000141	0.000609	CcSEcCtD
Cabazitaxel—Fatigue—Cyclosporine—psoriasis	0.000141	0.000609	CcSEcCtD
Cabazitaxel—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00014	0.000607	CcSEcCtD
Cabazitaxel—Pain—Cyclosporine—psoriasis	0.00014	0.000604	CcSEcCtD
Cabazitaxel—Constipation—Cyclosporine—psoriasis	0.00014	0.000604	CcSEcCtD
Cabazitaxel—Dry mouth—Triamcinolone—psoriasis	0.000139	0.000603	CcSEcCtD
Cabazitaxel—Renal failure—Methotrexate—psoriasis	0.000139	0.000602	CcSEcCtD
Cabazitaxel—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000139	0.000599	CcSEcCtD
Cabazitaxel—Anorexia—Hydrocortisone—psoriasis	0.000138	0.000599	CcSEcCtD
Cabazitaxel—Diarrhoea—Mycophenolic acid—psoriasis	0.000138	0.000598	CcSEcCtD
Cabazitaxel—Angiopathy—Prednisone—psoriasis	0.000138	0.000597	CcSEcCtD
Cabazitaxel—Conjunctivitis—Methotrexate—psoriasis	0.000138	0.000595	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000138	0.000595	CcSEcCtD
Cabazitaxel—Immune system disorder—Prednisone—psoriasis	0.000137	0.000594	CcSEcCtD
Cabazitaxel—Malaise—Betamethasone—psoriasis	0.000137	0.000593	CcSEcCtD
Cabazitaxel—Malaise—Dexamethasone—psoriasis	0.000137	0.000593	CcSEcCtD
Cabazitaxel—Oedema—Triamcinolone—psoriasis	0.000137	0.000591	CcSEcCtD
Cabazitaxel—Vertigo—Betamethasone—psoriasis	0.000137	0.000591	CcSEcCtD
Cabazitaxel—Vertigo—Dexamethasone—psoriasis	0.000137	0.000591	CcSEcCtD
Cabazitaxel—Pain—Mycophenolate mofetil—psoriasis	0.000136	0.000589	CcSEcCtD
Cabazitaxel—Constipation—Mycophenolate mofetil—psoriasis	0.000136	0.000589	CcSEcCtD
Cabazitaxel—Arrhythmia—Prednisone—psoriasis	0.000136	0.000588	CcSEcCtD
Cabazitaxel—Infection—Triamcinolone—psoriasis	0.000136	0.000587	CcSEcCtD
Cabazitaxel—Hypotension—Hydrocortisone—psoriasis	0.000136	0.000587	CcSEcCtD
Cabazitaxel—Haematuria—Methotrexate—psoriasis	0.000135	0.000584	CcSEcCtD
Cabazitaxel—Feeling abnormal—Cyclosporine—psoriasis	0.000135	0.000582	CcSEcCtD
Cabazitaxel—Alopecia—Prednisone—psoriasis	0.000134	0.000581	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Cyclosporine—psoriasis	0.000134	0.000578	CcSEcCtD
Cabazitaxel—Dizziness—Mycophenolic acid—psoriasis	0.000134	0.000578	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisolone—psoriasis	0.000133	0.000577	CcSEcCtD
Cabazitaxel—Tachycardia—Triamcinolone—psoriasis	0.000133	0.000577	CcSEcCtD
Cabazitaxel—Mental disorder—Prednisone—psoriasis	0.000133	0.000576	CcSEcCtD
Cabazitaxel—Erythema—Prednisone—psoriasis	0.000132	0.000573	CcSEcCtD
Cabazitaxel—Malnutrition—Prednisone—psoriasis	0.000132	0.000573	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000132	0.000572	CcSEcCtD
Cabazitaxel—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000131	0.000568	CcSEcCtD
Cabazitaxel—Hypertension—Dexamethasone—psoriasis	0.000131	0.000568	CcSEcCtD
Cabazitaxel—Hypertension—Betamethasone—psoriasis	0.000131	0.000568	CcSEcCtD
Cabazitaxel—Paraesthesia—Hydrocortisone—psoriasis	0.00013	0.000564	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00013	0.000564	CcSEcCtD
Cabazitaxel—Myalgia—Dexamethasone—psoriasis	0.000129	0.00056	CcSEcCtD
Cabazitaxel—Myalgia—Betamethasone—psoriasis	0.000129	0.00056	CcSEcCtD
Cabazitaxel—Body temperature increased—Cyclosporine—psoriasis	0.000129	0.000559	CcSEcCtD
Cabazitaxel—Abdominal pain—Cyclosporine—psoriasis	0.000129	0.000559	CcSEcCtD
Cabazitaxel—Anxiety—Betamethasone—psoriasis	0.000129	0.000558	CcSEcCtD
Cabazitaxel—Anxiety—Dexamethasone—psoriasis	0.000129	0.000558	CcSEcCtD
Cabazitaxel—Vomiting—Mycophenolic acid—psoriasis	0.000128	0.000555	CcSEcCtD
Cabazitaxel—Discomfort—Betamethasone—psoriasis	0.000128	0.000553	CcSEcCtD
Cabazitaxel—Discomfort—Dexamethasone—psoriasis	0.000128	0.000553	CcSEcCtD
Cabazitaxel—Dyspepsia—Hydrocortisone—psoriasis	0.000128	0.000553	CcSEcCtD
Cabazitaxel—Pain—Prednisolone—psoriasis	0.000127	0.00055	CcSEcCtD
Cabazitaxel—Headache—Mycophenolic acid—psoriasis	0.000127	0.000547	CcSEcCtD
Cabazitaxel—Decreased appetite—Hydrocortisone—psoriasis	0.000126	0.000546	CcSEcCtD
Cabazitaxel—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000126	0.000545	CcSEcCtD
Cabazitaxel—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000126	0.000545	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Methotrexate—psoriasis	0.000125	0.000543	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000125	0.000542	CcSEcCtD
Cabazitaxel—Fatigue—Hydrocortisone—psoriasis	0.000125	0.000541	CcSEcCtD
Cabazitaxel—Urethral disorder—Methotrexate—psoriasis	0.000125	0.000539	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000125	0.000539	CcSEcCtD
Cabazitaxel—Pain—Hydrocortisone—psoriasis	0.000124	0.000537	CcSEcCtD
Cabazitaxel—Oedema—Dexamethasone—psoriasis	0.000124	0.000537	CcSEcCtD
Cabazitaxel—Oedema—Betamethasone—psoriasis	0.000124	0.000537	CcSEcCtD
Cabazitaxel—Infection—Dexamethasone—psoriasis	0.000123	0.000533	CcSEcCtD
Cabazitaxel—Infection—Betamethasone—psoriasis	0.000123	0.000533	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Prednisone—psoriasis	0.000123	0.000531	CcSEcCtD
Cabazitaxel—Paraesthesia—Triamcinolone—psoriasis	0.000123	0.000531	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisolone—psoriasis	0.000122	0.00053	CcSEcCtD
Cabazitaxel—Anaemia—Prednisone—psoriasis	0.000122	0.000529	CcSEcCtD
Cabazitaxel—Dyspnoea—Triamcinolone—psoriasis	0.000122	0.000527	CcSEcCtD
Cabazitaxel—Nervous system disorder—Dexamethasone—psoriasis	0.000122	0.000526	CcSEcCtD
Cabazitaxel—Nervous system disorder—Betamethasone—psoriasis	0.000122	0.000526	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Betamethasone—psoriasis	0.000121	0.000525	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Dexamethasone—psoriasis	0.000121	0.000525	CcSEcCtD
Cabazitaxel—Tachycardia—Betamethasone—psoriasis	0.000121	0.000524	CcSEcCtD
Cabazitaxel—Tachycardia—Dexamethasone—psoriasis	0.000121	0.000524	CcSEcCtD
Cabazitaxel—Hypersensitivity—Cyclosporine—psoriasis	0.00012	0.000521	CcSEcCtD
Cabazitaxel—Dyspepsia—Triamcinolone—psoriasis	0.00012	0.000521	CcSEcCtD
Cabazitaxel—Nausea—Mycophenolic acid—psoriasis	0.00012	0.000519	CcSEcCtD
Cabazitaxel—Feeling abnormal—Hydrocortisone—psoriasis	0.00012	0.000517	CcSEcCtD
Cabazitaxel—Malaise—Prednisone—psoriasis	0.000119	0.000516	CcSEcCtD
Cabazitaxel—Vertigo—Prednisone—psoriasis	0.000119	0.000514	CcSEcCtD
Cabazitaxel—Eye disorder—Methotrexate—psoriasis	0.000119	0.000514	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000119	0.000514	CcSEcCtD
Cabazitaxel—Tinnitus—Methotrexate—psoriasis	0.000118	0.000512	CcSEcCtD
Cabazitaxel—Anorexia—Betamethasone—psoriasis	0.000118	0.000511	CcSEcCtD
Cabazitaxel—Anorexia—Dexamethasone—psoriasis	0.000118	0.000511	CcSEcCtD
Cabazitaxel—Cardiac disorder—Methotrexate—psoriasis	0.000118	0.00051	CcSEcCtD
Cabazitaxel—Fatigue—Triamcinolone—psoriasis	0.000118	0.00051	CcSEcCtD
Cabazitaxel—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000117	0.000508	CcSEcCtD
Cabazitaxel—Asthenia—Cyclosporine—psoriasis	0.000117	0.000507	CcSEcCtD
Cabazitaxel—Pain—Triamcinolone—psoriasis	0.000117	0.000506	CcSEcCtD
Cabazitaxel—Hypotension—Dexamethasone—psoriasis	0.000116	0.000501	CcSEcCtD
Cabazitaxel—Hypotension—Betamethasone—psoriasis	0.000116	0.000501	CcSEcCtD
Cabazitaxel—Angiopathy—Methotrexate—psoriasis	0.000115	0.000499	CcSEcCtD
Cabazitaxel—Immune system disorder—Methotrexate—psoriasis	0.000115	0.000496	CcSEcCtD
Cabazitaxel—Body temperature increased—Hydrocortisone—psoriasis	0.000115	0.000496	CcSEcCtD
Cabazitaxel—Abdominal pain—Hydrocortisone—psoriasis	0.000115	0.000496	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Methotrexate—psoriasis	0.000115	0.000495	CcSEcCtD
Cabazitaxel—Asthenia—Mycophenolate mofetil—psoriasis	0.000114	0.000495	CcSEcCtD
Cabazitaxel—Hypertension—Prednisone—psoriasis	0.000114	0.000494	CcSEcCtD
Cabazitaxel—Chills—Methotrexate—psoriasis	0.000114	0.000493	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000113	0.000489	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000113	0.000489	CcSEcCtD
Cabazitaxel—Myalgia—Prednisone—psoriasis	0.000113	0.000487	CcSEcCtD
Cabazitaxel—Arthralgia—Prednisone—psoriasis	0.000113	0.000487	CcSEcCtD
Cabazitaxel—Feeling abnormal—Triamcinolone—psoriasis	0.000113	0.000487	CcSEcCtD
Cabazitaxel—Anxiety—Prednisone—psoriasis	0.000112	0.000486	CcSEcCtD
Cabazitaxel—Alopecia—Methotrexate—psoriasis	0.000112	0.000486	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000112	0.000484	CcSEcCtD
Cabazitaxel—Diarrhoea—Cyclosporine—psoriasis	0.000112	0.000483	CcSEcCtD
Cabazitaxel—Paraesthesia—Betamethasone—psoriasis	0.000111	0.000482	CcSEcCtD
Cabazitaxel—Paraesthesia—Dexamethasone—psoriasis	0.000111	0.000482	CcSEcCtD
Cabazitaxel—Discomfort—Prednisone—psoriasis	0.000111	0.000482	CcSEcCtD
Cabazitaxel—Mental disorder—Methotrexate—psoriasis	0.000111	0.000482	CcSEcCtD
Cabazitaxel—Erythema—Methotrexate—psoriasis	0.000111	0.000478	CcSEcCtD
Cabazitaxel—Malnutrition—Methotrexate—psoriasis	0.000111	0.000478	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisolone—psoriasis	0.00011	0.000474	CcSEcCtD
Cabazitaxel—Dyspepsia—Dexamethasone—psoriasis	0.000109	0.000472	CcSEcCtD
Cabazitaxel—Dyspepsia—Betamethasone—psoriasis	0.000109	0.000472	CcSEcCtD
Cabazitaxel—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000109	0.000472	CcSEcCtD
Cabazitaxel—Dysgeusia—Methotrexate—psoriasis	0.000108	0.000469	CcSEcCtD
Cabazitaxel—Body temperature increased—Triamcinolone—psoriasis	0.000108	0.000467	CcSEcCtD
Cabazitaxel—Dizziness—Cyclosporine—psoriasis	0.000108	0.000467	CcSEcCtD
Cabazitaxel—Oedema—Prednisone—psoriasis	0.000108	0.000467	CcSEcCtD
Cabazitaxel—Decreased appetite—Dexamethasone—psoriasis	0.000108	0.000466	CcSEcCtD
Cabazitaxel—Decreased appetite—Betamethasone—psoriasis	0.000108	0.000466	CcSEcCtD
Cabazitaxel—Infection—Prednisone—psoriasis	0.000107	0.000464	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Betamethasone—psoriasis	0.000107	0.000463	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000107	0.000463	CcSEcCtD
Cabazitaxel—Back pain—Methotrexate—psoriasis	0.000107	0.000463	CcSEcCtD
Cabazitaxel—Hypersensitivity—Hydrocortisone—psoriasis	0.000107	0.000463	CcSEcCtD
Cabazitaxel—Fatigue—Dexamethasone—psoriasis	0.000107	0.000463	CcSEcCtD
Cabazitaxel—Fatigue—Betamethasone—psoriasis	0.000107	0.000463	CcSEcCtD
Cabazitaxel—Pain—Dexamethasone—psoriasis	0.000106	0.000459	CcSEcCtD
Cabazitaxel—Pain—Betamethasone—psoriasis	0.000106	0.000459	CcSEcCtD
Cabazitaxel—Nervous system disorder—Prednisone—psoriasis	0.000106	0.000458	CcSEcCtD
Cabazitaxel—Tachycardia—Prednisone—psoriasis	0.000105	0.000456	CcSEcCtD
Cabazitaxel—Dizziness—Mycophenolate mofetil—psoriasis	0.000105	0.000456	CcSEcCtD
Cabazitaxel—Skin disorder—Prednisone—psoriasis	0.000105	0.000454	CcSEcCtD
Cabazitaxel—Asthenia—Hydrocortisone—psoriasis	0.000104	0.000451	CcSEcCtD
Cabazitaxel—Vomiting—Cyclosporine—psoriasis	0.000104	0.000449	CcSEcCtD
Cabazitaxel—Anorexia—Prednisone—psoriasis	0.000103	0.000445	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Methotrexate—psoriasis	0.000103	0.000444	CcSEcCtD
Cabazitaxel—Headache—Cyclosporine—psoriasis	0.000102	0.000443	CcSEcCtD
Cabazitaxel—Anaemia—Methotrexate—psoriasis	0.000102	0.000442	CcSEcCtD
Cabazitaxel—Feeling abnormal—Betamethasone—psoriasis	0.000102	0.000442	CcSEcCtD
Cabazitaxel—Feeling abnormal—Dexamethasone—psoriasis	0.000102	0.000442	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Dexamethasone—psoriasis	0.000101	0.000439	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Betamethasone—psoriasis	0.000101	0.000439	CcSEcCtD
Cabazitaxel—Vomiting—Mycophenolate mofetil—psoriasis	0.000101	0.000438	CcSEcCtD
Cabazitaxel—Hypersensitivity—Triamcinolone—psoriasis	0.000101	0.000436	CcSEcCtD
Cabazitaxel—Headache—Mycophenolate mofetil—psoriasis	9.98e-05	0.000432	CcSEcCtD
Cabazitaxel—Malaise—Methotrexate—psoriasis	9.98e-05	0.000431	CcSEcCtD
Cabazitaxel—Vertigo—Methotrexate—psoriasis	9.94e-05	0.00043	CcSEcCtD
Cabazitaxel—Diarrhoea—Hydrocortisone—psoriasis	9.93e-05	0.00043	CcSEcCtD
Cabazitaxel—Leukopenia—Methotrexate—psoriasis	9.9e-05	0.000428	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Prednisone—psoriasis	9.84e-05	0.000426	CcSEcCtD
Cabazitaxel—Dizziness—Prednisolone—psoriasis	9.83e-05	0.000425	CcSEcCtD
Cabazitaxel—Asthenia—Triamcinolone—psoriasis	9.81e-05	0.000424	CcSEcCtD
Cabazitaxel—Body temperature increased—Betamethasone—psoriasis	9.81e-05	0.000424	CcSEcCtD
Cabazitaxel—Abdominal pain—Betamethasone—psoriasis	9.81e-05	0.000424	CcSEcCtD
Cabazitaxel—Body temperature increased—Dexamethasone—psoriasis	9.81e-05	0.000424	CcSEcCtD
Cabazitaxel—Abdominal pain—Dexamethasone—psoriasis	9.81e-05	0.000424	CcSEcCtD
Cabazitaxel—Nausea—Cyclosporine—psoriasis	9.7e-05	0.00042	CcSEcCtD
Cabazitaxel—Paraesthesia—Prednisone—psoriasis	9.7e-05	0.00042	CcSEcCtD
Cabazitaxel—Cough—Methotrexate—psoriasis	9.65e-05	0.000418	CcSEcCtD
Cabazitaxel—Dizziness—Hydrocortisone—psoriasis	9.6e-05	0.000415	CcSEcCtD
Cabazitaxel—Dyspepsia—Prednisone—psoriasis	9.51e-05	0.000411	CcSEcCtD
Cabazitaxel—Nausea—Mycophenolate mofetil—psoriasis	9.47e-05	0.000409	CcSEcCtD
Cabazitaxel—Chest pain—Methotrexate—psoriasis	9.42e-05	0.000407	CcSEcCtD
Cabazitaxel—Myalgia—Methotrexate—psoriasis	9.42e-05	0.000407	CcSEcCtD
Cabazitaxel—Arthralgia—Methotrexate—psoriasis	9.42e-05	0.000407	CcSEcCtD
Cabazitaxel—Decreased appetite—Prednisone—psoriasis	9.39e-05	0.000406	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	9.35e-05	0.000405	CcSEcCtD
Cabazitaxel—Fatigue—Prednisone—psoriasis	9.31e-05	0.000403	CcSEcCtD
Cabazitaxel—Headache—Prednisolone—psoriasis	9.31e-05	0.000403	CcSEcCtD
Cabazitaxel—Discomfort—Methotrexate—psoriasis	9.3e-05	0.000402	CcSEcCtD
Cabazitaxel—Constipation—Prednisone—psoriasis	9.24e-05	0.0004	CcSEcCtD
Cabazitaxel—Vomiting—Hydrocortisone—psoriasis	9.23e-05	0.000399	CcSEcCtD
Cabazitaxel—Confusional state—Methotrexate—psoriasis	9.1e-05	0.000394	CcSEcCtD
Cabazitaxel—Headache—Hydrocortisone—psoriasis	9.1e-05	0.000393	CcSEcCtD
Cabazitaxel—Dizziness—Triamcinolone—psoriasis	9.04e-05	0.000391	CcSEcCtD
Cabazitaxel—Infection—Methotrexate—psoriasis	8.97e-05	0.000388	CcSEcCtD
Cabazitaxel—Feeling abnormal—Prednisone—psoriasis	8.9e-05	0.000385	CcSEcCtD
Cabazitaxel—Asthenia—Dexamethasone—psoriasis	8.9e-05	0.000385	CcSEcCtD
Cabazitaxel—Asthenia—Betamethasone—psoriasis	8.9e-05	0.000385	CcSEcCtD
Cabazitaxel—Nervous system disorder—Methotrexate—psoriasis	8.85e-05	0.000383	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Methotrexate—psoriasis	8.84e-05	0.000382	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Prednisone—psoriasis	8.83e-05	0.000382	CcSEcCtD
Cabazitaxel—Nausea—Prednisolone—psoriasis	8.83e-05	0.000382	CcSEcCtD
Cabazitaxel—Skin disorder—Methotrexate—psoriasis	8.77e-05	0.000379	CcSEcCtD
Cabazitaxel—Vomiting—Triamcinolone—psoriasis	8.69e-05	0.000376	CcSEcCtD
Cabazitaxel—Nausea—Hydrocortisone—psoriasis	8.62e-05	0.000373	CcSEcCtD
Cabazitaxel—Anorexia—Methotrexate—psoriasis	8.61e-05	0.000372	CcSEcCtD
Cabazitaxel—Headache—Triamcinolone—psoriasis	8.56e-05	0.00037	CcSEcCtD
Cabazitaxel—Body temperature increased—Prednisone—psoriasis	8.54e-05	0.000369	CcSEcCtD
Cabazitaxel—Abdominal pain—Prednisone—psoriasis	8.54e-05	0.000369	CcSEcCtD
Cabazitaxel—Diarrhoea—Betamethasone—psoriasis	8.49e-05	0.000367	CcSEcCtD
Cabazitaxel—Diarrhoea—Dexamethasone—psoriasis	8.49e-05	0.000367	CcSEcCtD
Cabazitaxel—Hypotension—Methotrexate—psoriasis	8.44e-05	0.000365	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Methotrexate—psoriasis	8.22e-05	0.000356	CcSEcCtD
Cabazitaxel—Dizziness—Betamethasone—psoriasis	8.2e-05	0.000355	CcSEcCtD
Cabazitaxel—Dizziness—Dexamethasone—psoriasis	8.2e-05	0.000355	CcSEcCtD
Cabazitaxel—Nausea—Triamcinolone—psoriasis	8.12e-05	0.000351	CcSEcCtD
Cabazitaxel—Paraesthesia—Methotrexate—psoriasis	8.11e-05	0.000351	CcSEcCtD
Cabazitaxel—Dyspnoea—Methotrexate—psoriasis	8.05e-05	0.000348	CcSEcCtD
Cabazitaxel—Hypersensitivity—Prednisone—psoriasis	7.96e-05	0.000344	CcSEcCtD
Cabazitaxel—Dyspepsia—Methotrexate—psoriasis	7.95e-05	0.000344	CcSEcCtD
Cabazitaxel—Vomiting—Betamethasone—psoriasis	7.89e-05	0.000341	CcSEcCtD
Cabazitaxel—Vomiting—Dexamethasone—psoriasis	7.89e-05	0.000341	CcSEcCtD
Cabazitaxel—Decreased appetite—Methotrexate—psoriasis	7.85e-05	0.000339	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Methotrexate—psoriasis	7.79e-05	0.000337	CcSEcCtD
Cabazitaxel—Fatigue—Methotrexate—psoriasis	7.78e-05	0.000337	CcSEcCtD
Cabazitaxel—Headache—Dexamethasone—psoriasis	7.77e-05	0.000336	CcSEcCtD
Cabazitaxel—Headache—Betamethasone—psoriasis	7.77e-05	0.000336	CcSEcCtD
Cabazitaxel—Asthenia—Prednisone—psoriasis	7.75e-05	0.000335	CcSEcCtD
Cabazitaxel—Pain—Methotrexate—psoriasis	7.72e-05	0.000334	CcSEcCtD
Cabazitaxel—Feeling abnormal—Methotrexate—psoriasis	7.44e-05	0.000322	CcSEcCtD
Cabazitaxel—Diarrhoea—Prednisone—psoriasis	7.39e-05	0.00032	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Methotrexate—psoriasis	7.38e-05	0.000319	CcSEcCtD
Cabazitaxel—Nausea—Betamethasone—psoriasis	7.37e-05	0.000319	CcSEcCtD
Cabazitaxel—Nausea—Dexamethasone—psoriasis	7.37e-05	0.000319	CcSEcCtD
Cabazitaxel—Dizziness—Prednisone—psoriasis	7.14e-05	0.000309	CcSEcCtD
Cabazitaxel—Abdominal pain—Methotrexate—psoriasis	7.14e-05	0.000309	CcSEcCtD
Cabazitaxel—Body temperature increased—Methotrexate—psoriasis	7.14e-05	0.000309	CcSEcCtD
Cabazitaxel—Vomiting—Prednisone—psoriasis	6.87e-05	0.000297	CcSEcCtD
Cabazitaxel—Headache—Prednisone—psoriasis	6.77e-05	0.000293	CcSEcCtD
Cabazitaxel—Hypersensitivity—Methotrexate—psoriasis	6.65e-05	0.000288	CcSEcCtD
Cabazitaxel—Asthenia—Methotrexate—psoriasis	6.48e-05	0.00028	CcSEcCtD
Cabazitaxel—Nausea—Prednisone—psoriasis	6.42e-05	0.000278	CcSEcCtD
Cabazitaxel—Diarrhoea—Methotrexate—psoriasis	6.18e-05	0.000267	CcSEcCtD
Cabazitaxel—Dizziness—Methotrexate—psoriasis	5.97e-05	0.000258	CcSEcCtD
Cabazitaxel—Vomiting—Methotrexate—psoriasis	5.74e-05	0.000248	CcSEcCtD
Cabazitaxel—Headache—Methotrexate—psoriasis	5.66e-05	0.000245	CcSEcCtD
Cabazitaxel—Nausea—Methotrexate—psoriasis	5.36e-05	0.000232	CcSEcCtD
Cabazitaxel—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	5.26e-05	0.0604	CbGpPWpGaD
Cabazitaxel—CYP3A5—Xenobiotics—CYP2S1—psoriasis	3.76e-05	0.0433	CbGpPWpGaD
Cabazitaxel—CYP2C8—Xenobiotics—CYP2S1—psoriasis	3.26e-05	0.0375	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL22—psoriasis	2.28e-05	0.0262	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—SERPINB8—psoriasis	1.99e-05	0.0229	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	1.88e-05	0.0217	CbGpPWpGaD
Cabazitaxel—CYP3A4—Xenobiotics—CYP2S1—psoriasis	1.75e-05	0.0201	CbGpPWpGaD
Cabazitaxel—TUBB6—Orphan transporters—CARM1—psoriasis	1.62e-05	0.0187	CbGpPWpGaD
Cabazitaxel—TUBB2B—Orphan transporters—CARM1—psoriasis	1.62e-05	0.0187	CbGpPWpGaD
Cabazitaxel—TUBB3—Orphan transporters—CARM1—psoriasis	1.57e-05	0.018	CbGpPWpGaD
Cabazitaxel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.56e-05	0.018	CbGpPWpGaD
Cabazitaxel—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.54e-05	0.0177	CbGpPWpGaD
Cabazitaxel—TUBB2A—Orphan transporters—CARM1—psoriasis	1.52e-05	0.0175	CbGpPWpGaD
Cabazitaxel—TUBB1—Orphan transporters—CARM1—psoriasis	1.49e-05	0.0171	CbGpPWpGaD
Cabazitaxel—ABCG2—Iron uptake and transport—CP—psoriasis	1.46e-05	0.0168	CbGpPWpGaD
Cabazitaxel—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	1.35e-05	0.0156	CbGpPWpGaD
Cabazitaxel—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	1.33e-05	0.0154	CbGpPWpGaD
Cabazitaxel—TUBB4A—Orphan transporters—CARM1—psoriasis	1.33e-05	0.0153	CbGpPWpGaD
Cabazitaxel—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.27e-05	0.0146	CbGpPWpGaD
Cabazitaxel—TUBB4B—Orphan transporters—CARM1—psoriasis	1.22e-05	0.014	CbGpPWpGaD
Cabazitaxel—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	1.1e-05	0.0126	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—CP—psoriasis	1.03e-05	0.0119	CbGpPWpGaD
Cabazitaxel—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	9.42e-06	0.0108	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—PTTG1—psoriasis	7.33e-06	0.00843	CbGpPWpGaD
Cabazitaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	7.26e-06	0.00835	CbGpPWpGaD
Cabazitaxel—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	7.16e-06	0.00824	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—CYP2S1—psoriasis	6.72e-06	0.00773	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	6.63e-06	0.00763	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—PTTG1—psoriasis	6.55e-06	0.00754	CbGpPWpGaD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—psoriasis	6.49e-06	0.00746	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—PTTG1—psoriasis	6.23e-06	0.00717	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet degranulation—VEGFA—psoriasis	6.02e-06	0.00693	CbGpPWpGaD
Cabazitaxel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	5.89e-06	0.00677	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—CYP2S1—psoriasis	5.82e-06	0.0067	CbGpPWpGaD
Cabazitaxel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	5.81e-06	0.00668	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—ITGAL—psoriasis	5.79e-06	0.00666	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	5.74e-06	0.00661	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	5.74e-06	0.0066	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	5.59e-06	0.00643	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—PTTG1—psoriasis	5.57e-06	0.00641	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	5.55e-06	0.00638	CbGpPWpGaD
Cabazitaxel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	5.41e-06	0.00623	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—REN—psoriasis	5.18e-06	0.00595	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—PTTG1—psoriasis	5.16e-06	0.00594	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—PTTG1—psoriasis	4.72e-06	0.00543	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—LEP—psoriasis	4.71e-06	0.00542	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—PTTG1—psoriasis	4.62e-06	0.00531	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—REN—psoriasis	4.44e-06	0.00511	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—REN—psoriasis	4.44e-06	0.00511	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—NOS2—psoriasis	4.39e-06	0.00505	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—VEGFA—psoriasis	4.33e-06	0.00497	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-C—psoriasis	4.31e-06	0.00496	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—REN—psoriasis	4.29e-06	0.00493	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL13—psoriasis	4.29e-06	0.00493	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—PTTG1—psoriasis	4.22e-06	0.00486	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—CP—psoriasis	4.16e-06	0.00478	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—CP—psoriasis	4.16e-06	0.00478	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—REN—psoriasis	4.15e-06	0.00478	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—REN—psoriasis	4.06e-06	0.00467	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—CP—psoriasis	4.01e-06	0.00462	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—CARM1—psoriasis	3.96e-06	0.00456	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—CARM1—psoriasis	3.96e-06	0.00456	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL17A—psoriasis	3.95e-06	0.00454	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—CP—psoriasis	3.89e-06	0.00447	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—CARM1—psoriasis	3.83e-06	0.0044	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—CP—psoriasis	3.8e-06	0.00437	CbGpPWpGaD
Cabazitaxel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	3.77e-06	0.00434	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	3.73e-06	0.00429	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—CARM1—psoriasis	3.71e-06	0.00427	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL12B—psoriasis	3.67e-06	0.00422	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—REN—psoriasis	3.65e-06	0.0042	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.63e-06	0.00417	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-E—psoriasis	3.58e-06	0.00412	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—CP—psoriasis	3.41e-06	0.00393	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—psoriasis	3.35e-06	0.00385	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—REN—psoriasis	3.34e-06	0.00384	CbGpPWpGaD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.33e-06	0.00384	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—CARM1—psoriasis	3.26e-06	0.00374	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—ACE—psoriasis	3.23e-06	0.00372	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.13e-06	0.0036	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—CP—psoriasis	3.12e-06	0.00359	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.08e-06	0.00355	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NDUFA5—psoriasis	3.03e-06	0.00349	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—PCNA—psoriasis	2.99e-06	0.00343	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—CARM1—psoriasis	2.98e-06	0.00342	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	2.96e-06	0.00341	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—JUN—psoriasis	2.91e-06	0.00335	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.83e-06	0.00325	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	2.82e-06	0.00324	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—ACE—psoriasis	2.77e-06	0.00319	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—ACE—psoriasis	2.77e-06	0.00319	CbGpPWpGaD
Cabazitaxel—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.7e-06	0.0031	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	2.69e-06	0.00309	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL10—psoriasis	2.68e-06	0.00309	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—ACE—psoriasis	2.68e-06	0.00308	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—psoriasis	2.67e-06	0.00307	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—PCNA—psoriasis	2.67e-06	0.00307	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IL4—psoriasis	2.61e-06	0.003	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—ACE—psoriasis	2.59e-06	0.00298	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CYP2S1—psoriasis	2.58e-06	0.00297	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.55e-06	0.00293	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.55e-06	0.00293	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—VEGFA—psoriasis	2.54e-06	0.00293	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—PCNA—psoriasis	2.54e-06	0.00292	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—ACE—psoriasis	2.54e-06	0.00292	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NOS2—psoriasis	2.38e-06	0.00273	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	2.37e-06	0.00273	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-A—psoriasis	2.36e-06	0.00272	CbGpPWpGaD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.32e-06	0.00267	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—ACE—psoriasis	2.28e-06	0.00262	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—PCNA—psoriasis	2.27e-06	0.00261	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	2.16e-06	0.00248	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—PCNA—psoriasis	2.1e-06	0.00242	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—ACE—psoriasis	2.08e-06	0.00239	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NDUFA5—psoriasis	2.04e-06	0.00234	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—LEP—psoriasis	2.01e-06	0.00231	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—PCNA—psoriasis	1.92e-06	0.00221	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.9e-06	0.00219	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	1.89e-06	0.00218	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NDUFA5—psoriasis	1.89e-06	0.00217	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—PCNA—psoriasis	1.88e-06	0.00216	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	1.81e-06	0.00208	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—CP—psoriasis	1.75e-06	0.00202	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CYP2S1—psoriasis	1.73e-06	0.00199	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—LEP—psoriasis	1.72e-06	0.00198	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—LEP—psoriasis	1.72e-06	0.00198	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—PCNA—psoriasis	1.72e-06	0.00198	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—CARM1—psoriasis	1.67e-06	0.00193	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—LEP—psoriasis	1.66e-06	0.00191	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—LEP—psoriasis	1.61e-06	0.00185	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CYP2S1—psoriasis	1.61e-06	0.00185	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—IFNG—psoriasis	1.58e-06	0.00181	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—LEP—psoriasis	1.57e-06	0.00181	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.57e-06	0.00181	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.47e-06	0.00169	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—LEP—psoriasis	1.41e-06	0.00163	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—VEGFA—psoriasis	1.38e-06	0.00158	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.38e-06	0.00158	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NDUFA5—psoriasis	1.35e-06	0.00156	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.35e-06	0.00156	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—CXCL8—psoriasis	1.33e-06	0.00153	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—LEP—psoriasis	1.29e-06	0.00149	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CARM1—psoriasis	1.26e-06	0.00145	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	1.21e-06	0.00139	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—VEGFA—psoriasis	1.19e-06	0.00137	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-06	0.00135	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NDUFA5—psoriasis	1.17e-06	0.00135	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CYP2S1—psoriasis	1.15e-06	0.00132	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—CXCL8—psoriasis	1.14e-06	0.00132	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—CXCL8—psoriasis	1.14e-06	0.00132	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—CXCL8—psoriasis	1.11e-06	0.00127	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.09e-06	0.00126	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—CXCL8—psoriasis	1.07e-06	0.00123	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—CXCL8—psoriasis	1.05e-06	0.0012	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—psoriasis	1.04e-06	0.0012	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—TNF—psoriasis	1.02e-06	0.00117	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NDUFA5—psoriasis	1.02e-06	0.00117	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.01e-06	0.00117	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CYP2S1—psoriasis	9.96e-07	0.00115	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—psoriasis	9.82e-07	0.00113	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	9.49e-07	0.00109	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—CXCL8—psoriasis	9.4e-07	0.00108	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.08e-07	0.00104	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	9.05e-07	0.00104	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CYP2S1—psoriasis	8.68e-07	0.000998	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—CXCL8—psoriasis	8.59e-07	0.000988	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CARM1—psoriasis	8.47e-07	0.000974	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—psoriasis	8.35e-07	0.00096	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.91e-07	0.00091	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CARM1—psoriasis	7.84e-07	0.000902	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—CAT—psoriasis	7.75e-07	0.000891	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—psoriasis	6.92e-07	0.000796	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	6.73e-07	0.000774	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	6.48e-07	0.000745	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—psoriasis	6.33e-07	0.000728	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NDUFA5—psoriasis	6.29e-07	0.000723	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—APOE—psoriasis	6.02e-07	0.000693	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	5.88e-07	0.000676	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CARM1—psoriasis	5.62e-07	0.000646	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CYP2S1—psoriasis	5.35e-07	0.000615	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPARG—psoriasis	5.25e-07	0.000603	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.22e-07	0.0006	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CAT—psoriasis	5.21e-07	0.000599	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.04e-07	0.000579	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CARM1—psoriasis	4.86e-07	0.00056	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CAT—psoriasis	4.82e-07	0.000555	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.55e-07	0.000523	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	4.44e-07	0.000511	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CARM1—psoriasis	4.24e-07	0.000487	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—APOE—psoriasis	4.05e-07	0.000465	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—APOE—psoriasis	3.75e-07	0.000431	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARG—psoriasis	3.52e-07	0.000405	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CAT—psoriasis	3.45e-07	0.000397	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARG—psoriasis	3.26e-07	0.000375	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CAT—psoriasis	2.99e-07	0.000344	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—APOE—psoriasis	2.68e-07	0.000309	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CARM1—psoriasis	2.61e-07	0.0003	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CAT—psoriasis	2.61e-07	0.0003	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARG—psoriasis	2.34e-07	0.000269	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—APOE—psoriasis	2.32e-07	0.000267	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—APOE—psoriasis	2.03e-07	0.000233	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARG—psoriasis	2.03e-07	0.000233	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARG—psoriasis	1.76e-07	0.000203	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CAT—psoriasis	1.61e-07	0.000185	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—APOE—psoriasis	1.25e-07	0.000144	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARG—psoriasis	1.09e-07	0.000125	CbGpPWpGaD
